146 related articles for article (PubMed ID: 38775977)
1. Bruton tyrosine kinase degrader BP001 attenuates the inflammation caused by high glucose in raw264.7 cell.
Lin J; Chen Z; Lu Y; Shi H; Lin P
In Vitro Cell Dev Biol Anim; 2024 May; ():. PubMed ID: 38775977
[TBL] [Abstract][Full Text] [Related]
2. Inhibitor of Bruton's tyrosine kinases, PCI-32765, decreases pro-inflammatory mediators' production in high glucose-induced macrophages.
Fan Z; Wang Y; Xu X; Wu Y
Int Immunopharmacol; 2018 May; 58():145-153. PubMed ID: 29587203
[TBL] [Abstract][Full Text] [Related]
3. Discovery of Ibrutinib-based BTK PROTACs with in vivo anti-inflammatory efficacy by inhibiting NF-κB activation.
Huang J; Ma Z; Yang Z; He Z; Bao J; Peng X; Liu Y; Chen T; Cai S; Chen J; Zeng Z
Eur J Med Chem; 2023 Nov; 259():115664. PubMed ID: 37487306
[TBL] [Abstract][Full Text] [Related]
4. Urolithin A attenuates pro-inflammatory mediator production by suppressing PI3-K/Akt/NF-κB and JNK/AP-1 signaling pathways in lipopolysaccharide-stimulated RAW264 macrophages: Possible involvement of NADPH oxidase-derived reactive oxygen species.
Komatsu W; Kishi H; Yagasaki K; Ohhira S
Eur J Pharmacol; 2018 Aug; 833():411-424. PubMed ID: 29932926
[TBL] [Abstract][Full Text] [Related]
5. Anti-inflammatory activity of myricetin from Diospyros lotus through suppression of NF-κB and STAT1 activation and Nrf2-mediated HO-1 induction in lipopolysaccharide-stimulated RAW264.7 macrophages.
Cho BO; Yin HH; Park SH; Byun EB; Ha HY; Jang SI
Biosci Biotechnol Biochem; 2016 Aug; 80(8):1520-30. PubMed ID: 27068250
[TBL] [Abstract][Full Text] [Related]
6. Ginsenoside Rg5:Rk1 attenuates TNF-α/IFN-γ-induced production of thymus- and activation-regulated chemokine (TARC/CCL17) and LPS-induced NO production via downregulation of NF-κB/p38 MAPK/STAT1 signaling in human keratinocytes and macrophages.
Ahn S; Siddiqi MH; Aceituno VC; Simu SY; Zhang J; Jimenez Perez ZE; Kim YJ; Yang DC
In Vitro Cell Dev Biol Anim; 2016 Mar; 52(3):287-295. PubMed ID: 26714752
[TBL] [Abstract][Full Text] [Related]
7. Inhibition of Bruton's TK regulates macrophage NF-κB and NLRP3 inflammasome activation in metabolic inflammation.
Purvis GSD; Collino M; Aranda-Tavio H; Chiazza F; O'Riordan CE; Zeboudj L; Mohammad S; Collotta D; Verta R; Guisot NES; Bunyard P; Yaqoob MM; Greaves DR; Thiemermann C
Br J Pharmacol; 2020 Oct; 177(19):4416-4432. PubMed ID: 32608058
[TBL] [Abstract][Full Text] [Related]
8. Enhanced Bruton's tyrosine kinase activity in the kidney of patients with IgA nephropathy.
Wei J; Wang Y; Qi X; Wu Y
Int Urol Nephrol; 2021 Jul; 53(7):1399-1415. PubMed ID: 33389462
[TBL] [Abstract][Full Text] [Related]
9. Knockout of Bruton's tyrosine kinase in macrophages attenuates diabetic nephropathy in streptozotocin-induced mice.
Fan Z; Li Y; Xia L; Wu Y
Am J Transl Res; 2021; 13(11):12352-12363. PubMed ID: 34956457
[TBL] [Abstract][Full Text] [Related]
10. The p38 MAPK inhibitor JLU1124 inhibits the inflammatory response induced by lipopolysaccharide through the MAPK-NF-κB pathway in RAW264.7 macrophages.
Li XN; Su J; Zhao L; Xiang JB; Wang W; Liu F; Li HY; Zhong JT; Bai X; Sun LK
Int Immunopharmacol; 2013 Nov; 17(3):785-92. PubMed ID: 24070708
[TBL] [Abstract][Full Text] [Related]
11. Anti-inflammatory effects of Aureusidin in LPS-stimulated RAW264.7 macrophages via suppressing NF-κB and activating ROS- and MAPKs-dependent Nrf2/HO-1 signaling pathways.
Ren J; Su D; Li L; Cai H; Zhang M; Zhai J; Li M; Wu X; Hu K
Toxicol Appl Pharmacol; 2020 Jan; 387():114846. PubMed ID: 31790703
[TBL] [Abstract][Full Text] [Related]
12. 7b, a novel naphthalimide derivative, exhibited anti-inflammatory effects via targeted-inhibiting TAK1 following down-regulation of ERK1/2- and p38 MAPK-mediated activation of NF-κB in LPS-stimulated RAW264.7 macrophages.
Shao J; Li Y; Wang Z; Xiao M; Yin P; Lu Y; Qian X; Xu Y; Liu J
Int Immunopharmacol; 2013 Oct; 17(2):216-28. PubMed ID: 23810444
[TBL] [Abstract][Full Text] [Related]
13. Degradation of IkappaBalpha in activated RAW264.7 cells is blocked by the phosphatidylinositol 3-kinase inhibitor LY294002.
Park SJ; Lee SC; Hong SH; Kim HM
Cell Biol Toxicol; 2002; 18(2):121-30. PubMed ID: 12046690
[TBL] [Abstract][Full Text] [Related]
14. Stauntoside B inhibits macrophage activation by inhibiting NF-κB and ERK MAPK signalling.
Liu J; Tang J; Zuo Y; Yu Y; Luo P; Yao X; Dong Y; Wang P; Liu L; Zhou H
Pharmacol Res; 2016 Sep; 111():303-315. PubMed ID: 27343699
[TBL] [Abstract][Full Text] [Related]
15. Macrophage effector functions controlled by Bruton's tyrosine kinase are more crucial than the cytokine balance of T cell responses for microfilarial clearance.
Mukhopadhyay S; Mohanty M; Mangla A; George A; Bal V; Rath S; Ravindran B
J Immunol; 2002 Mar; 168(6):2914-21. PubMed ID: 11884462
[TBL] [Abstract][Full Text] [Related]
16. Anti-inflammatory effect of lovastatin is mediated via the modulation of NF-κB and inhibition of HDAC1 and the PI3K/Akt/mTOR pathway in RAW264.7 macrophages.
Choi HW; Shin PG; Lee JH; Choi WS; Kang MJ; Kong WS; Oh MJ; Seo YB; Kim GD
Int J Mol Med; 2018 Feb; 41(2):1103-1109. PubMed ID: 29207042
[TBL] [Abstract][Full Text] [Related]
17. Er-Miao-San, a traditional herbal formula containing Rhizoma Atractylodis and Cortex Phellodendri inhibits inflammatory mediators in LPS-stimulated RAW264.7 macrophages through inhibition of NF-κB pathway and MAPKs activation.
Chen G; Li KK; Fung CH; Liu CL; Wong HL; Leung PC; Ko CH
J Ethnopharmacol; 2014 Jul; 154(3):711-8. PubMed ID: 24815219
[TBL] [Abstract][Full Text] [Related]
18. Synergistic effect of Bruton's tyrosine kinase and TNF-α in the regulation of rheumatoid arthritis and underlying mechanisms.
Du J
Exp Ther Med; 2022 Feb; 23(2):141. PubMed ID: 35069822
[TBL] [Abstract][Full Text] [Related]
19. Ethyl acetate fraction from Nymphaea hybrida Peck modulates inflammatory responses in LPS-stimulated RAW 264.7 cells and acute inflammation murine models.
Zhang Z; Jiang S; Tian H; Zeng Y; He K; Lin L; Yu F
J Ethnopharmacol; 2021 Apr; 269():113698. PubMed ID: 33338590
[TBL] [Abstract][Full Text] [Related]
20. Anti-inflammatory Potential of
Gutierrez RMP; Hoyo-Vadillo C
Pharmacogn Mag; 2017 Jul; 13(Suppl 2):S174-S178. PubMed ID: 28808377
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
